Your session is about to expire
← Back to Search
Androgen Replacement Therapy
Natesto for Low Testosterone
Phase 4
Waitlist Available
Research Sponsored by Acerus Pharmaceuticals Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day 0) and day 120
Awards & highlights
Study Summary
This trial will test whether testosterone therapy can help lower blood pressure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (day 0) and day 120
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day 0) and day 120
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change From Baseline in 24-Hour Systolic Blood Pressure (SBP) At Day 120
Secondary outcome measures
Change From Baseline in 24-hour Average Diastolic Blood Pressure (DBP)
Change From Baseline in 24-hour Average Heart Rate
Change From Baseline in 24-hour Average Mean Arterial Pressure (MAP)
+9 moreSide effects data
From 2020 Phase 4 trial • 60 Patients • NCT032036818%
Nasal Irritation
5%
Severe Oligospermia
2%
Epistaxis
2%
Sinusitis
2%
Azoospermia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Natesto
Trial Design
1Treatment groups
Experimental Treatment
Group I: NatestoExperimental Treatment1 Intervention
Participants will administer Natesto, gel, intranasally, three times daily up to Day 120. A multiple-dose dispenser will be used for gel deposition into the nasal cavity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Natesto
2017
Completed Phase 4
~280
Find a Location
Who is running the clinical trial?
Acerus Pharmaceuticals CorporationLead Sponsor
13 Previous Clinical Trials
6,198 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Florida
Other
California
Texas
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How old are they?
65+
18 - 65
What site did they apply to?
Precision Clinical Research
Prime Revival Research Institute
Valley Clinical Trials
Other
How many prior treatments have patients received?
0
2
How responsive is this trial?
Average response time
- < 1 Day
Typically responds via
Email
Most responsive sites:
- Baylor College of Medicine: < 24 hours
Share this study with friends
Copy Link
Messenger